HK Stock MarketDetailed Quotes

NT PHARMA (01011)

Watchlist
  • 0.610
  • -0.020-3.17%
Market Closed May 15 13:58 CST
578.89MMarket Cap-20.33P/E (TTM)

NT PHARMA (01011) Income Statement

All
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q6)Jun 30, 2025
(FY)Dec 31, 2024
(Q6)Jun 30, 2024
(FY)Dec 31, 2023
(Q6)Jun 30, 2023
(FY)Dec 31, 2022
(Q6)Jun 30, 2022
(FY)Dec 31, 2021
(Q6)Jun 30, 2021
Turnover
-36.36%24.16M
-61.67%12M
415.34%37.96M
324.88%31.3M
--7.37M
-93.89%7.37M
----
8.33%120.5M
2.24%226.7M
24.37%111.23M
Operating income
-36.36%24.16M
-61.67%12M
415.34%37.96M
324.88%31.3M
7.37M
-93.89%7.37M
8.33%120.5M
2.24%226.7M
24.37%111.23M
Cost of sales
55.51%-14.55M
92.25%-1.98M
---32.7M
---25.59M
----
----
----
-15.31%-45.63M
6.43%-81.24M
-20.87%-39.57M
Operating expenses
55.51%-14.55M
92.25%-1.98M
-32.7M
-25.59M
-15.31%-45.63M
6.43%-81.24M
-20.87%-39.57M
Gross profit
82.70%9.61M
75.46%10.01M
-28.59%5.26M
-22.54%5.71M
7.37M
-90.16%7.37M
4.48%74.87M
7.82%145.46M
26.39%71.66M
Selling expenses
---8.24M
-7,027.27%-3.92M
----
---55K
----
----
----
7.04%-48.75M
----
-36.47%-52.44M
Administrative expenses
25.68%-13.74M
12.15%-6.19M
70.92%-18.49M
30.31%-7.05M
-181.03%-63.57M
61.61%-10.11M
---22.62M
27.21%-26.33M
----
18.53%-36.18M
Profit from asset sales
----
----
----
----
--12.27M
----
----
----
----
----
Revaluation surplus
337.69%14.08M
---2.22M
---5.92M
----
----
----
----
----
----
----
-Changes in the fair value of financial assets
337.69%14.08M
---2.22M
---5.92M
----
----
----
----
----
----
----
Impairment and provision
----
----
----
----
----
----
---3.92M
----
----
----
-Other impairment is provision
----
----
----
----
----
----
---3.92M
----
----
----
Special items of operating profit
99.03%-127K
-97.94%6K
-655.50%-13.03M
29,000.00%291K
-65.82%2.35M
-99.99%1K
-65.98%6.86M
-82.79%7.79M
-25.27%20.18M
1,468.98%45.27M
Operating profit
104.93%1.59M
-109.34%-2.31M
22.63%-32.18M
59.77%-1.1M
-111.35%-41.59M
-136.16%-2.74M
-111.88%-19.68M
-73.21%7.58M
2.31%165.64M
231.97%28.31M
Financing cost
11.74%-27.84M
-143.08%-14.6M
-9.46%-31.54M
54.13%-6.01M
26.79%-28.82M
62.46%-13.09M
55.63%-39.37M
-9.30%-34.87M
-2.53%-88.73M
-17.96%-31.9M
Share of profits of associates
----
----
-72.34%10.24M
-28.49%7.89M
311.41%37.04M
--11.04M
-73.90%9M
----
431,025.00%34.49M
----
Special items of earning before tax
----
----
----
----
----
----
----
----
5.63%-260.15M
----
Earning before tax
50.91%-26.26M
-2,253.63%-16.91M
-60.27%-53.48M
116.37%785K
33.32%-33.37M
82.43%-4.8M
66.36%-50.04M
-659.29%-27.29M
25.73%-148.75M
92.59%-3.59M
Tax
----
----
200.82%123K
---124K
---122K
----
----
---949K
-128.63%-2.58M
----
After-tax profit from continuing operations
50.79%-26.26M
-2,657.64%-16.91M
-59.32%-53.36M
113.78%661K
33.07%-33.49M
83.02%-4.8M
66.93%-50.04M
-685.70%-28.24M
20.88%-151.33M
92.59%-3.59M
After-tax profit from non-continuing business
----
----
----
----
-572.77%-110.1M
---816K
---16.37M
----
----
----
Special items of earning after tax
----
----
----
----
-572.77%-110.1M
---816K
---16.37M
----
----
----
Earning after tax
50.79%-26.26M
-2,657.64%-16.91M
62.84%-53.36M
111.78%661K
-116.23%-143.59M
80.13%-5.61M
56.12%-66.41M
-685.70%-28.24M
57.95%-151.33M
95.77%-3.59M
Minority profit
---214K
----
----
----
----
----
----
----
22.39%-1.8M
46.41%-940K
Shareholders should account for profits from continuing business
----
----
----
----
33.07%-33.49M
---4.8M
---50.04M
----
----
----
Shareholders should account for profits from non-continuing business
----
----
----
----
-572.77%-110.1M
---816K
---16.37M
----
----
----
Profit attributable to shareholders
51.19%-26.04M
-2,657.64%-16.91M
62.84%-53.36M
111.78%661K
-116.23%-143.59M
80.13%-5.61M
55.59%-66.41M
-963.98%-28.24M
58.18%-149.54M
96.81%-2.65M
Basic earnings per share
79.11%-0.0422
-1,312.00%-0.0303
66.45%-0.202
200.00%0.0025
-1,624.93%-0.602
83.22%-0.0025
55.88%-0.0349
-964.29%-0.0149
58.26%-0.0791
96.80%-0.0014
Diluted earnings per share
79.11%-0.0422
-1,312.00%-0.0303
66.45%-0.202
200.00%0.0025
-1,624.93%-0.602
83.22%-0.0025
55.88%-0.0349
-964.29%-0.0149
58.26%-0.0791
96.80%-0.0014
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
(FY)Dec 31, 2025(Q6)Jun 30, 2025(FY)Dec 31, 2024(Q6)Jun 30, 2024(FY)Dec 31, 2023(Q6)Jun 30, 2023(FY)Dec 31, 2022(Q6)Jun 30, 2022(FY)Dec 31, 2021(Q6)Jun 30, 2021
Turnover -36.36%24.16M-61.67%12M415.34%37.96M324.88%31.3M--7.37M-93.89%7.37M----8.33%120.5M2.24%226.7M24.37%111.23M
Operating income -36.36%24.16M-61.67%12M415.34%37.96M324.88%31.3M7.37M-93.89%7.37M8.33%120.5M2.24%226.7M24.37%111.23M
Cost of sales 55.51%-14.55M92.25%-1.98M---32.7M---25.59M-------------15.31%-45.63M6.43%-81.24M-20.87%-39.57M
Operating expenses 55.51%-14.55M92.25%-1.98M-32.7M-25.59M-15.31%-45.63M6.43%-81.24M-20.87%-39.57M
Gross profit 82.70%9.61M75.46%10.01M-28.59%5.26M-22.54%5.71M7.37M-90.16%7.37M4.48%74.87M7.82%145.46M26.39%71.66M
Selling expenses ---8.24M-7,027.27%-3.92M-------55K------------7.04%-48.75M-----36.47%-52.44M
Administrative expenses 25.68%-13.74M12.15%-6.19M70.92%-18.49M30.31%-7.05M-181.03%-63.57M61.61%-10.11M---22.62M27.21%-26.33M----18.53%-36.18M
Profit from asset sales ------------------12.27M--------------------
Revaluation surplus 337.69%14.08M---2.22M---5.92M----------------------------
-Changes in the fair value of financial assets 337.69%14.08M---2.22M---5.92M----------------------------
Impairment and provision ---------------------------3.92M------------
-Other impairment is provision ---------------------------3.92M------------
Special items of operating profit 99.03%-127K-97.94%6K-655.50%-13.03M29,000.00%291K-65.82%2.35M-99.99%1K-65.98%6.86M-82.79%7.79M-25.27%20.18M1,468.98%45.27M
Operating profit 104.93%1.59M-109.34%-2.31M22.63%-32.18M59.77%-1.1M-111.35%-41.59M-136.16%-2.74M-111.88%-19.68M-73.21%7.58M2.31%165.64M231.97%28.31M
Financing cost 11.74%-27.84M-143.08%-14.6M-9.46%-31.54M54.13%-6.01M26.79%-28.82M62.46%-13.09M55.63%-39.37M-9.30%-34.87M-2.53%-88.73M-17.96%-31.9M
Share of profits of associates ---------72.34%10.24M-28.49%7.89M311.41%37.04M--11.04M-73.90%9M----431,025.00%34.49M----
Special items of earning before tax --------------------------------5.63%-260.15M----
Earning before tax 50.91%-26.26M-2,253.63%-16.91M-60.27%-53.48M116.37%785K33.32%-33.37M82.43%-4.8M66.36%-50.04M-659.29%-27.29M25.73%-148.75M92.59%-3.59M
Tax --------200.82%123K---124K---122K-----------949K-128.63%-2.58M----
After-tax profit from continuing operations 50.79%-26.26M-2,657.64%-16.91M-59.32%-53.36M113.78%661K33.07%-33.49M83.02%-4.8M66.93%-50.04M-685.70%-28.24M20.88%-151.33M92.59%-3.59M
After-tax profit from non-continuing business -----------------572.77%-110.1M---816K---16.37M------------
Special items of earning after tax -----------------572.77%-110.1M---816K---16.37M------------
Earning after tax 50.79%-26.26M-2,657.64%-16.91M62.84%-53.36M111.78%661K-116.23%-143.59M80.13%-5.61M56.12%-66.41M-685.70%-28.24M57.95%-151.33M95.77%-3.59M
Minority profit ---214K----------------------------22.39%-1.8M46.41%-940K
Shareholders should account for profits from continuing business ----------------33.07%-33.49M---4.8M---50.04M------------
Shareholders should account for profits from non-continuing business -----------------572.77%-110.1M---816K---16.37M------------
Profit attributable to shareholders 51.19%-26.04M-2,657.64%-16.91M62.84%-53.36M111.78%661K-116.23%-143.59M80.13%-5.61M55.59%-66.41M-963.98%-28.24M58.18%-149.54M96.81%-2.65M
Basic earnings per share 79.11%-0.0422-1,312.00%-0.030366.45%-0.202200.00%0.0025-1,624.93%-0.60283.22%-0.002555.88%-0.0349-964.29%-0.014958.26%-0.079196.80%-0.0014
Diluted earnings per share 79.11%-0.0422-1,312.00%-0.030366.45%-0.202200.00%0.0025-1,624.93%-0.60283.22%-0.002555.88%-0.0349-964.29%-0.014958.26%-0.079196.80%-0.0014
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards HKASHKASHKASHKASHKASHKASHKASHKASHKASHKAS

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
China and the US begin implementing the Kuala Lumpur economic and trade consultation consensus.
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More